Global Betahistine Market Growth 2022-2028

Publisher Name :
Date: 20-Jan-2022
No. of pages: 104

As the global economy mends, the 2021 growth of Betahistine will have significant change from previous year. According to our (LP Information) latest study, the global Betahistine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Betahistine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Betahistine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Betahistine market, reaching US$ million by the year 2028. As for the Europe Betahistine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Betahistine players cover TOWA PHARMACEUTICAL CO., LTD, Nichi-Iko Pharmaceutical, Takeda Pharmaceutical Company Limited, and EA Pharma Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Betahistine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

- 8mg

- 25mg

- Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

- Cerebral Thrombosis

- Cerebral Embolism

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

- TOWA PHARMACEUTICAL CO., LTD

- Nichi-Iko Pharmaceutical

- Takeda Pharmaceutical Company Limited

- EA Pharma Co., Ltd.

- Disphar International B.V.

- HENNIG ARZNEIMITTEL GmbH & Co. KG

- DOC Generici

- Ciclum Farma Unipessoal

- Mylan

- Orion Corporation

Global Betahistine Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Betahistine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Betahistine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Betahistine by Country/Region, 2017, 2022 & 2028
2.2 Betahistine Segment by Type
2.2.1 8mg
2.2.2 25mg
2.2.3 Others
2.3 Betahistine Sales by Type
2.3.1 Global Betahistine Sales Market Share by Type (2017-2022)
2.3.2 Global Betahistine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Betahistine Sale Price by Type (2017-2022)
2.4 Betahistine Segment by Application
2.4.1 Cerebral Thrombosis
2.4.2 Cerebral Embolism
2.4.3 Others
2.5 Betahistine Sales by Application
2.5.1 Global Betahistine Sale Market Share by Application (2017-2022)
2.5.2 Global Betahistine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Betahistine Sale Price by Application (2017-2022)
3 Global Betahistine by Company
3.1 Global Betahistine Breakdown Data by Company
3.1.1 Global Betahistine Annual Sales by Company (2020-2022)
3.1.2 Global Betahistine Sales Market Share by Company (2020-2022)
3.2 Global Betahistine Annual Revenue by Company (2020-2022)
3.2.1 Global Betahistine Revenue by Company (2020-2022)
3.2.2 Global Betahistine Revenue Market Share by Company (2020-2022)
3.3 Global Betahistine Sale Price by Company
3.4 Key Manufacturers Betahistine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Betahistine Product Location Distribution
3.4.2 Players Betahistine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Betahistine by Geographic Region
4.1 World Historic Betahistine Market Size by Geographic Region (2017-2022)
4.1.1 Global Betahistine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Betahistine Annual Revenue by Geographic Region
4.2 World Historic Betahistine Market Size by Country/Region (2017-2022)
4.2.1 Global Betahistine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Betahistine Annual Revenue by Country/Region
4.3 Americas Betahistine Sales Growth
4.4 APAC Betahistine Sales Growth
4.5 Europe Betahistine Sales Growth
4.6 Middle East & Africa Betahistine Sales Growth
5 Americas
5.1 Americas Betahistine Sales by Country
5.1.1 Americas Betahistine Sales by Country (2017-2022)
5.1.2 Americas Betahistine Revenue by Country (2017-2022)
5.2 Americas Betahistine Sales by Type
5.3 Americas Betahistine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Betahistine Sales by Region
6.1.1 APAC Betahistine Sales by Region (2017-2022)
6.1.2 APAC Betahistine Revenue by Region (2017-2022)
6.2 APAC Betahistine Sales by Type
6.3 APAC Betahistine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Betahistine by Country
7.1.1 Europe Betahistine Sales by Country (2017-2022)
7.1.2 Europe Betahistine Revenue by Country (2017-2022)
7.2 Europe Betahistine Sales by Type
7.3 Europe Betahistine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Betahistine by Country
8.1.1 Middle East & Africa Betahistine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Betahistine Revenue by Country (2017-2022)
8.2 Middle East & Africa Betahistine Sales by Type
8.3 Middle East & Africa Betahistine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Betahistine
10.3 Manufacturing Process Analysis of Betahistine
10.4 Industry Chain Structure of Betahistine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Betahistine Distributors
11.3 Betahistine Customer
12 World Forecast Review for Betahistine by Geographic Region
12.1 Global Betahistine Market Size Forecast by Region
12.1.1 Global Betahistine Forecast by Region (2023-2028)
12.1.2 Global Betahistine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Betahistine Forecast by Type
12.7 Global Betahistine Forecast by Application
13 Key Players Analysis
13.1 TOWA PHARMACEUTICAL CO., LTD
13.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information
13.1.2 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Offered
13.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 TOWA PHARMACEUTICAL CO., LTD Main Business Overview
13.1.5 TOWA PHARMACEUTICAL CO., LTD Latest Developments
13.2 Nichi-Iko Pharmaceutical
13.2.1 Nichi-Iko Pharmaceutical Company Information
13.2.2 Nichi-Iko Pharmaceutical Betahistine Product Offered
13.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Nichi-Iko Pharmaceutical Main Business Overview
13.2.5 Nichi-Iko Pharmaceutical Latest Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Takeda Pharmaceutical Company Limited Company Information
13.3.2 Takeda Pharmaceutical Company Limited Betahistine Product Offered
13.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.3.5 Takeda Pharmaceutical Company Limited Latest Developments
13.4 EA Pharma Co., Ltd.
13.4.1 EA Pharma Co., Ltd. Company Information
13.4.2 EA Pharma Co., Ltd. Betahistine Product Offered
13.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 EA Pharma Co., Ltd. Main Business Overview
13.4.5 EA Pharma Co., Ltd. Latest Developments
13.5 Disphar International B.V.
13.5.1 Disphar International B.V. Company Information
13.5.2 Disphar International B.V. Betahistine Product Offered
13.5.3 Disphar International B.V. Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Disphar International B.V. Main Business Overview
13.5.5 Disphar International B.V. Latest Developments
13.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
13.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
13.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Offered
13.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business Overview
13.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
13.7 DOC Generici
13.7.1 DOC Generici Company Information
13.7.2 DOC Generici Betahistine Product Offered
13.7.3 DOC Generici Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 DOC Generici Main Business Overview
13.7.5 DOC Generici Latest Developments
13.8 Ciclum Farma Unipessoal
13.8.1 Ciclum Farma Unipessoal Company Information
13.8.2 Ciclum Farma Unipessoal Betahistine Product Offered
13.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ciclum Farma Unipessoal Main Business Overview
13.8.5 Ciclum Farma Unipessoal Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Betahistine Product Offered
13.9.3 Mylan Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Orion Corporation
13.10.1 Orion Corporation Company Information
13.10.2 Orion Corporation Betahistine Product Offered
13.10.3 Orion Corporation Betahistine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Orion Corporation Main Business Overview
13.10.5 Orion Corporation Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Betahistine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Betahistine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 8mg
Table 4. Major Players of 25mg
Table 5. Major Players of Others
Table 6. Global Betahistine Sales by Type (2017-2022) & (K Units)
Table 7. Global Betahistine Sales Market Share by Type (2017-2022)
Table 8. Global Betahistine Revenue by Type (2017-2022) & ($ million)
Table 9. Global Betahistine Revenue Market Share by Type (2017-2022)
Table 10. Global Betahistine Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Betahistine Sales by Application (2017-2022) & (K Units)
Table 12. Global Betahistine Sales Market Share by Application (2017-2022)
Table 13. Global Betahistine Revenue by Application (2017-2022)
Table 14. Global Betahistine Revenue Market Share by Application (2017-2022)
Table 15. Global Betahistine Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Betahistine Sales by Company (2020-2022) & (K Units)
Table 17. Global Betahistine Sales Market Share by Company (2020-2022)
Table 18. Global Betahistine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Betahistine Revenue Market Share by Company (2020-2022)
Table 20. Global Betahistine Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Betahistine Producing Area Distribution and Sales Area
Table 22. Players Betahistine Products Offered
Table 23. Betahistine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Betahistine Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Betahistine Sales Market Share Geographic Region (2017-2022)
Table 28. Global Betahistine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Betahistine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Betahistine Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Betahistine Sales Market Share by Country/Region (2017-2022)
Table 32. Global Betahistine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Betahistine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Betahistine Sales by Country (2017-2022) & (K Units)
Table 35. Americas Betahistine Sales Market Share by Country (2017-2022)
Table 36. Americas Betahistine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Betahistine Revenue Market Share by Country (2017-2022)
Table 38. Americas Betahistine Sales by Type (2017-2022) & (K Units)
Table 39. Americas Betahistine Sales Market Share by Type (2017-2022)
Table 40. Americas Betahistine Sales by Application (2017-2022) & (K Units)
Table 41. Americas Betahistine Sales Market Share by Application (2017-2022)
Table 42. APAC Betahistine Sales by Region (2017-2022) & (K Units)
Table 43. APAC Betahistine Sales Market Share by Region (2017-2022)
Table 44. APAC Betahistine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Betahistine Revenue Market Share by Region (2017-2022)
Table 46. APAC Betahistine Sales by Type (2017-2022) & (K Units)
Table 47. APAC Betahistine Sales Market Share by Type (2017-2022)
Table 48. APAC Betahistine Sales by Application (2017-2022) & (K Units)
Table 49. APAC Betahistine Sales Market Share by Application (2017-2022)
Table 50. Europe Betahistine Sales by Country (2017-2022) & (K Units)
Table 51. Europe Betahistine Sales Market Share by Country (2017-2022)
Table 52. Europe Betahistine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Betahistine Revenue Market Share by Country (2017-2022)
Table 54. Europe Betahistine Sales by Type (2017-2022) & (K Units)
Table 55. Europe Betahistine Sales Market Share by Type (2017-2022)
Table 56. Europe Betahistine Sales by Application (2017-2022) & (K Units)
Table 57. Europe Betahistine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Betahistine Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Betahistine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Betahistine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Betahistine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Betahistine Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Betahistine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Betahistine Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Betahistine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Betahistine
Table 67. Key Market Challenges & Risks of Betahistine
Table 68. Key Industry Trends of Betahistine
Table 69. Betahistine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Betahistine Distributors List
Table 72. Betahistine Customer List
Table 73. Global Betahistine Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Betahistine Sales Market Forecast by Region
Table 75. Global Betahistine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Betahistine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Betahistine Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Betahistine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Betahistine Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Betahistine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Betahistine Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Betahistine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Betahistine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Betahistine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Betahistine Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Betahistine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Betahistine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Betahistine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Betahistine Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Betahistine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Betahistine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Betahistine Revenue Market Share Forecast by Application (2023-2028)
Table 93. TOWA PHARMACEUTICAL CO., LTD Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 94. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Offered
Table 95. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. TOWA PHARMACEUTICAL CO., LTD Main Business
Table 97. TOWA PHARMACEUTICAL CO., LTD Latest Developments
Table 98. Nichi-Iko Pharmaceutical Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 99. Nichi-Iko Pharmaceutical Betahistine Product Offered
Table 100. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Nichi-Iko Pharmaceutical Main Business
Table 102. Nichi-Iko Pharmaceutical Latest Developments
Table 103. Takeda Pharmaceutical Company Limited Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 104. Takeda Pharmaceutical Company Limited Betahistine Product Offered
Table 105. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Takeda Pharmaceutical Company Limited Main Business
Table 107. Takeda Pharmaceutical Company Limited Latest Developments
Table 108. EA Pharma Co., Ltd. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 109. EA Pharma Co., Ltd. Betahistine Product Offered
Table 110. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. EA Pharma Co., Ltd. Main Business
Table 112. EA Pharma Co., Ltd. Latest Developments
Table 113. Disphar International B.V. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 114. Disphar International B.V. Betahistine Product Offered
Table 115. Disphar International B.V. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Disphar International B.V. Main Business
Table 117. Disphar International B.V. Latest Developments
Table 118. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 119. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Offered
Table 120. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business
Table 122. HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
Table 123. DOC Generici Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 124. DOC Generici Betahistine Product Offered
Table 125. DOC Generici Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. DOC Generici Main Business
Table 127. DOC Generici Latest Developments
Table 128. Ciclum Farma Unipessoal Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 129. Ciclum Farma Unipessoal Betahistine Product Offered
Table 130. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Ciclum Farma Unipessoal Main Business
Table 132. Ciclum Farma Unipessoal Latest Developments
Table 133. Mylan Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 134. Mylan Betahistine Product Offered
Table 135. Mylan Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Mylan Main Business
Table 137. Mylan Latest Developments
Table 138. Orion Corporation Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 139. Orion Corporation Betahistine Product Offered
Table 140. Orion Corporation Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Orion Corporation Main Business
Table 142. Orion Corporation Latest Developments
List of Figures
Figure 1. Picture of Betahistine
Figure 2. Betahistine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Betahistine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Betahistine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Betahistine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 8mg
Figure 10. Product Picture of 25mg
Figure 11. Product Picture of Others
Figure 12. Global Betahistine Sales Market Share by Type in 2021
Figure 13. Global Betahistine Revenue Market Share by Type (2017-2022)
Figure 14. Betahistine Consumed in Cerebral Thrombosis
Figure 15. Global Betahistine Market: Cerebral Thrombosis (2017-2022) & (K Units)
Figure 16. Betahistine Consumed in Cerebral Embolism
Figure 17. Global Betahistine Market: Cerebral Embolism (2017-2022) & (K Units)
Figure 18. Betahistine Consumed in Others
Figure 19. Global Betahistine Market: Others (2017-2022) & (K Units)
Figure 20. Global Betahistine Sales Market Share by Application (2017-2022)
Figure 21. Global Betahistine Revenue Market Share by Application in 2021
Figure 22. Betahistine Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Betahistine Revenue Market Share by Company in 2021
Figure 24. Global Betahistine Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Betahistine Revenue Market Share by Geographic Region in 2021
Figure 26. Global Betahistine Sales Market Share by Region (2017-2022)
Figure 27. Global Betahistine Revenue Market Share by Country/Region in 2021
Figure 28. Americas Betahistine Sales 2017-2022 (K Units)
Figure 29. Americas Betahistine Revenue 2017-2022 ($ Millions)
Figure 30. APAC Betahistine Sales 2017-2022 (K Units)
Figure 31. APAC Betahistine Revenue 2017-2022 ($ Millions)
Figure 32. Europe Betahistine Sales 2017-2022 (K Units)
Figure 33. Europe Betahistine Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Betahistine Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Betahistine Revenue 2017-2022 ($ Millions)
Figure 36. Americas Betahistine Sales Market Share by Country in 2021
Figure 37. Americas Betahistine Revenue Market Share by Country in 2021
Figure 38. United States Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Betahistine Sales Market Share by Region in 2021
Figure 43. APAC Betahistine Revenue Market Share by Regions in 2021
Figure 44. China Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Betahistine Sales Market Share by Country in 2021
Figure 51. Europe Betahistine Revenue Market Share by Country in 2021
Figure 52. Germany Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Betahistine Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Betahistine Revenue Market Share by Country in 2021
Figure 59. Egypt Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Betahistine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Betahistine in 2021
Figure 65. Manufacturing Process Analysis of Betahistine
Figure 66. Industry Chain Structure of Betahistine
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs